Chengxing Lu

1.3k total citations
20 papers, 921 citations indexed

About

Chengxing Lu is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Infectious Diseases. According to data from OpenAlex, Chengxing Lu has authored 20 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Ophthalmology and 3 papers in Infectious Diseases. Recurrent topics in Chengxing Lu's work include Retinal Diseases and Treatments (5 papers), Retinal and Optic Conditions (5 papers) and Retinal Imaging and Analysis (5 papers). Chengxing Lu is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Retinal and Optic Conditions (5 papers) and Retinal Imaging and Analysis (5 papers). Chengxing Lu collaborates with scholars based in United States, Italy and France. Chengxing Lu's co-authors include Csaba Siffel, Adolfo Correa, James E. Kucik, Mikyong Shin, Lilah M. Besser, Gary M. Shaw, Giovanni Staurenghi, Paul Mitchell, Christian Simader and Ursula Schmidt‐Erfurth and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Ophthalmology.

In The Last Decade

Chengxing Lu

20 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengxing Lu United States 15 223 220 212 147 130 20 921
Maja Popović Italy 18 122 0.5× 44 0.2× 192 0.9× 104 0.7× 152 1.2× 69 1.0k
Richard Bowman United Kingdom 27 172 0.8× 557 2.5× 831 3.9× 272 1.9× 77 0.6× 121 2.1k
Laura M. Katz United States 13 186 0.8× 94 0.4× 144 0.7× 29 0.2× 78 0.6× 22 820
Mahdi A. Shkoukani United States 20 128 0.6× 68 0.3× 63 0.3× 31 0.2× 176 1.4× 44 1.1k
Erin M. Shriver United States 15 152 0.7× 91 0.4× 562 2.7× 43 0.3× 18 0.1× 67 1.2k
Keith D. Carter United States 27 449 2.0× 180 0.8× 813 3.8× 52 0.4× 85 0.7× 99 2.3k
Eduarda Matos Portugal 18 109 0.5× 229 1.0× 22 0.1× 25 0.2× 103 0.8× 40 887
John L. Bell United States 22 102 0.5× 73 0.3× 29 0.1× 121 0.8× 296 2.3× 69 1.4k
Shirley M. L. Tse Canada 24 152 0.7× 32 0.1× 30 0.1× 313 2.1× 108 0.8× 64 1.8k
Earl H. Harley United States 21 184 0.8× 45 0.2× 23 0.1× 67 0.5× 299 2.3× 62 1.3k

Countries citing papers authored by Chengxing Lu

Since Specialization
Citations

This map shows the geographic impact of Chengxing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxing Lu more than expected).

Fields of papers citing papers by Chengxing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengxing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxing Lu. The network helps show where Chengxing Lu may publish in the future.

Co-authorship network of co-authors of Chengxing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengxing Lu. A scholar is included among the top collaborators of Chengxing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengxing Lu. Chengxing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinn, David I., Daniel P. Petrylak, Joaquim Bellmunt, et al.. (2020). FORT-1: Phase II/III study of rogaratinib versus chemotherapy (CT) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) selected based on FGFR1/3 mRNA expression.. Journal of Clinical Oncology. 38(6_suppl). 489–489. 26 indexed citations
2.
Korobelnik, Jean‐François, et al.. (2019). Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies. Ophthalmology Retina. 3(8). 663–669. 22 indexed citations
3.
Mitchell, Paul, Michael Larsen, Giovanni Staurenghi, et al.. (2018). Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies. Ophthalmology Retina. 2(10). 988–996. 44 indexed citations
4.
Midena, Edoardo, et al.. (2018). Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies. Journal of Ophthalmology. 2018. 1–9. 7 indexed citations
5.
Staurenghi, Giovanni, Nicolas Feltgen, Jennifer Arnold, et al.. (2017). Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies. British Journal of Ophthalmology. 102(7). 954–958. 15 indexed citations
6.
Morris, Michael J., Yohann Loriot, Karim Fizazi, et al.. (2017). Effects of radium-223 (Ra-223) with docetaxel versus docetaxel alone on bone biomarkers in patients with bone-metastatic castration-resistant prostate cancer (CRPC): A phase I/IIa clinical trial.. Journal of Clinical Oncology. 35(6_suppl). 154–154. 9 indexed citations
7.
Waldstein, Sebastian M., Christian Simader, Giovanni Staurenghi, et al.. (2016). Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials. Ophthalmology. 123(7). 1521–1529. 131 indexed citations
8.
Rossi, Andrea, Thys van der Molen, Alberto Papi, et al.. (2015). INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms results. PA1023–PA1023. 1 indexed citations
9.
Rossi, Andrea, Thys van der Molen, Alberto Papi, et al.. (2014). INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. European Respiratory Journal. 44(6). 1548–1556. 90 indexed citations
10.
Gonem, Sherif, Rachid Berair, Amisha Singapuri, et al.. (2014). Late-breaking abstract: Phase 2a randomized placebo-controlled trial of the oral prostaglandin D2 receptor (DP2/ CRTh2) antagonist QAWo39 in eosinophilic asthma. 44. 2908. 6 indexed citations
11.
Squires, Kathleen, Linda‐Gail Bekker, Joseph J. Eron, et al.. (2013). Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study. AIDS Research and Human Retroviruses. 29(6). 859–870. 16 indexed citations
12.
Shin, Mikyong, James E. Kucik, Csaba Siffel, et al.. (2012). Improved Survival Among Children with Spina Bifida in the United States. The Journal of Pediatrics. 161(6). 1132–1137.e3. 86 indexed citations
13.
Gotuzzo, Eduardo, Martin Markowitz, Winai Ratanasuwan, et al.. (2012). Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(1). 73–77. 19 indexed citations
14.
Shin, Mikyong, Lilah M. Besser, Csaba Siffel, et al.. (2010). Prevalence of Spina Bifida Among Children and Adolescents in 10 Regions in the United States. PEDIATRICS. 126(2). 274–279. 85 indexed citations
15.
Miller, Assia, Csaba Siffel, Chengxing Lu, et al.. (2010). Long-Term Survival of Infants with Atrioventricular Septal Defects. The Journal of Pediatrics. 156(6). 994–1000. 25 indexed citations
16.
Shin, Mikyong, Lilah M. Besser, Csaba Siffel, et al.. (2010). Spina Bifida Prevalence among Children in Ten Regions of the United States. 1 indexed citations
17.
Shin, Mikyong, Lilah M. Besser, James E. Kucik, et al.. (2009). Prevalence of Down Syndrome Among Children and Adolescents in 10 Regions of the United States. PEDIATRICS. 124(6). 1565–1571. 192 indexed citations
18.
Houry, Debra, Nadine J. Kaslow, Robin S. Kemball, et al.. (2008). Does Screening in the Emergency Department Hurt or Help Victims of Intimate Partner Violence?. Annals of Emergency Medicine. 51(4). 433–442.e7. 101 indexed citations
19.
Ofotokun, Ighovwerha, et al.. (2007). Liver Enzymes Elevation and Immune Reconstitution Among Treatment-Naïve HIV-Infected Patients Instituting Antiretroviral Therapy. The American Journal of the Medical Sciences. 334(5). 334–341. 27 indexed citations
20.
Bowman, F. DuBois, R. B. Patel, & Chengxing Lu. (2004). Methods for detecting functional classifications in neuroimaging data. Human Brain Mapping. 23(2). 109–119. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maja Popović Breakdown of academic impact, for papers by Richard Bowman Breakdown of academic impact, for papers by Laura M. Katz Breakdown of academic impact, for papers by Mahdi A. Shkoukani Breakdown of academic impact, for papers by Erin M. Shriver Breakdown of academic impact, for papers by Keith D. Carter Breakdown of academic impact, for papers by Eduarda Matos Breakdown of academic impact, for papers by John L. Bell Breakdown of academic impact, for papers by Shirley M. L. Tse Breakdown of academic impact, for papers by Earl H. Harley
Rankless by CCL
2026